Medication Collaboration for Dementia: A Feasibility Study
Official title: Feasibility Study of a Brief Intervention to Support Medication Collaboration Among Older Adults and Family Care Partners
Run by Northwestern University · NCT07742189 · Data updated 2026-11-12
This study tests a short, joint medication-management session for people 60+ with early dementia or mild cognitive impairment and their family caregivers to see if it’s workable and helps with taking medicines and beliefs about dementia and independence.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 60 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Northwestern University Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Status | Recruiting |
| Started | August 3, 2026 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | August 14, 2026 |
| Trial ID | NCT07742189 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Older adults (60+) with dementia or MCI who take three or more medications and have an involved family caregiver, and who are proficient in English.
✕Probably not a fit
Patients who do not benefit may include those with severe cognitive impairment, inability to consent, or non-English speakers.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Older adults with mild dementia or MCI and their family caregivers will take part in a brief baseline interview, followed by a 45–60 minute virtual intervention led by an interventionist. The session covers medication responsibilities, education on dementia and medication management, and cognitive steps to address beliefs about independence and caregiver help. Participants will collaboratively plan medication tasks and discuss how to handle multiple medications. The study will measure feasibility and acceptability, as well as changes in medication collaboration, adherence, and beliefs about autonomy. Recruitment is at Northwestern University in Chicago, with English-speaking participants.
Why it matters
Potential benefit: If successful, participants may experience clearer roles in medication management and improved adherence and autonomy beliefs.
How similar studies have gone: Previous work in caregiver-supported medication management has shown feasibility and some benefits in similar populations, but this exact virtual collaboration approach is exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria for older adults with dementia: 1. Age 60 or older 2. Diagnosis of dementia, Alzhimer's Disease or Mild Cognitive Impairment 3. Quick Dementia Rating Scale Score 2-12 (inclusive of mild cognitive impairment and mild dementia) 4. Taking 3 or more medications 5. Involved with managing their medications 6. Proficient speaking English 7. Capacity to provide consent Inclusion criteria for caregivers include:: 1. Primary family caregiver for the past 3 months 2. Age 18 or older 3. Proficient speaking English Exclusion Criteria: * adults unable to consent
Where it's running
-
Northwestern University
Chicago, Illinois, United States Recruiting
Study contacts
- Study coordinator: Rachel O'Conor
- Email: r-oconor@northwestern.edu
- Phone: 13125033240
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Diabetes, Dementia, and Oxidative Stress: A look at Nox2-related markers
This study tests whether oxidative stress linked to Nox2 is related to dementia risk in adults with type 2 diabetes.
-
China HEAD: a large community study on healthy aging and dementia
This study tests whether collecting health, imaging, and biospecimen data from adults in China can help predict who will develop Alzheimer’s disease and related dementias.
-
Doll Therapy for Apathy and Daily Living in Older Adults with Dementia
This study tests whether doll therapy helps reduce apathy and improves starting daily activities in older adults with dementia.
-
Aging Brain Health Initiative in Fujian
This observational study will follow about 3,000 older adults in Fujian to see how Alzheimer's-related changes develop and to test new digital tests, biomarkers, and imaging tools for early diagnosis.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Blood biomarker cohort for memory disorders in older adults
This observational cohort will collect blood samples and brain imaging data from adults 50+ with memory disorders and a small group of healthy young adults to help find biomarkers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.